Microvascular obstruction (MO) or no-reflow phenomenon is an established complication of coronary reperfusion therapy for acute myocardial infarction. It is increasingly recognized as a poor prognostic indicator and marker of subsequent adverse LV remodeling. Microvascular obstruction (MO) or no-reflow phenomenon is an established complication of coronary reperfusion therapy for acute myocardial infarction. It is increasingly recognized as a poor prognostic indicator and marker of subsequent adverse LV remodeling.
(2022). Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR. Cardiovascular Research Prove Journal, 6(1), -. doi: 10.21608/cvrepj.2022.351472
MLA
. "Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR", Cardiovascular Research Prove Journal, 6, 1, 2022, -. doi: 10.21608/cvrepj.2022.351472
HARVARD
(2022). 'Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR', Cardiovascular Research Prove Journal, 6(1), pp. -. doi: 10.21608/cvrepj.2022.351472
VANCOUVER
Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR. Cardiovascular Research Prove Journal, 2022; 6(1): -. doi: 10.21608/cvrepj.2022.351472
)
View on SCiNiTO